BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 16086599)

  • 1. Anti-inflammatory medications for cystic fibrosis lung disease: selecting the most appropriate agent.
    Chmiel JF; Konstan MW
    Treat Respir Med; 2005; 4(4):255-73. PubMed ID: 16086599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of airway inflammation in cystic fibrosis.
    Konstan MW
    Curr Opin Pulm Med; 1996 Nov; 2(6):452-6. PubMed ID: 9363184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of inflammation in the pathophysiology of CF lung disease.
    Chmiel JF; Berger M; Konstan MW
    Clin Rev Allergy Immunol; 2002 Aug; 23(1):5-27. PubMed ID: 12162106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis.
    Konstan MW; Davis PB
    Adv Drug Deliv Rev; 2002 Dec; 54(11):1409-23. PubMed ID: 12458152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapies aimed at airway inflammation in cystic fibrosis.
    Konstan MW
    Clin Chest Med; 1998 Sep; 19(3):505-13, vi. PubMed ID: 9759552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory approaches to the treatment of cystic fibrosis lung disease: past, present and future.
    Oermann CM
    Curr Opin Investig Drugs; 2001 Jul; 2(7):900-6. PubMed ID: 11757788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of modulators of airways inflammation in patients with CF.
    Ren CL
    Clin Rev Allergy Immunol; 2002 Aug; 23(1):29-39. PubMed ID: 12162104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and anti-inflammatory therapies for cystic fibrosis.
    Chmiel JF; Konstan MW
    Clin Chest Med; 2007 Jun; 28(2):331-46. PubMed ID: 17467552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting airway inflammation in cystic fibrosis.
    McElvaney OJ; Wade P; Murphy M; Reeves EP; McElvaney NG
    Expert Rev Respir Med; 2019 Nov; 13(11):1041-1055. PubMed ID: 31530195
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of anti-inflammatory medications in cystic fibrosis: trends and physician attitudes.
    Oermann CM; Sockrider MM; Konstan MW
    Chest; 1999 Apr; 115(4):1053-8. PubMed ID: 10208207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation in cystic fibrosis: An update.
    Roesch EA; Nichols DP; Chmiel JF
    Pediatr Pulmonol; 2018 Nov; 53(S3):S30-S50. PubMed ID: 29999593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung inflammation as a therapeutic target in cystic fibrosis.
    Koehler DR; Downey GP; Sweezey NB; Tanswell AK; Hu J
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):377-81. PubMed ID: 15381503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of inhaled corticosteroids in the management of cystic fibrosis.
    Ross KR; Chmiel JF; Konstan MW
    Paediatr Drugs; 2009; 11(2):101-13. PubMed ID: 19301932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting airway inflammation in cystic fibrosis in children: past, present, and future.
    Pressler T
    Paediatr Drugs; 2011 Jun; 13(3):141-7. PubMed ID: 21500868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cystic fibrosis inflammation in the age of CFTR modulators: focus on macrophages.
    Gillan JL; Davidson DJ; Gray RD
    Eur Respir J; 2021 Jun; 57(6):. PubMed ID: 33303535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady-State Therapy with Azithromycin or Low-Dose Prednisolone in Paediatric Cystic Fibrosis Patients: Inflammatory Markers and Disease Progression.
    Shmarina G; Pukhalsky A; Avakian L; Semykin S; Pukhalskaya D; Alioshkin V
    Int Arch Allergy Immunol; 2017; 172(1):45-54. PubMed ID: 28219060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines and inflammatory mediators in cystic fibrosis.
    Courtney JM; Ennis M; Elborn JS
    J Cyst Fibros; 2004 Dec; 3(4):223-31. PubMed ID: 15698939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis.
    Lands LC; Stanojevic S
    Cochrane Database Syst Rev; 2007 Oct; (4):CD001505. PubMed ID: 17943753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New and emerging therapies for pulmonary complications of cystic fibrosis.
    Tonelli MR; Aitken ML
    Drugs; 2001; 61(10):1379-85. PubMed ID: 11558827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and cystic fibrosis pulmonary disease.
    Kennedy MJ
    Pharmacotherapy; 2001 May; 21(5):593-603. PubMed ID: 11349748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.